|
DNAJB11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.45970005369389E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.50609999996598E-06 |
| Normal-vs-Stage2 |
4.605600E-04 |
| Normal-vs-Stage3 |
6.73416877816635E-12 |
| Normal-vs-Stage4 |
3.58459995020155E-09 |
| Stage1-vs-Stage2 |
8.029200E-01 |
| Stage1-vs-Stage3 |
3.550700E-04 |
| Stage1-vs-Stage4 |
7.735700E-03 |
| Stage2-vs-Stage3 |
6.456200E-03 |
| Stage2-vs-Stage4 |
1.376080E-02 |
| Stage3-vs-Stage4 |
8.545200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.47599718505853E-11 |
| Normal-vs-AfricanAmerican |
4.798200E-04 |
| Normal-vs-Asian |
2.47049999999582E-05 |
| Caucasian-vs-AfricanAmerican |
7.690200E-01 |
| Caucasian-vs-Asian |
2.745400E-01 |
| AfricanAmerican-vs-Asian |
6.625600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.036599996597E-08 |
| Normal-vs-Female |
1.63000000164004E-08 |
| Male-vs-Female |
8.852200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.28690000000564E-05 |
| Normal-vs-Age(41-60Yrs) |
1.38180022979384E-10 |
| Normal-vs-Age(61-80Yrs) |
6.72190003658812E-09 |
| Normal-vs-Age(81-100Yrs) |
2.010800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.514300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.817500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.461200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.571200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.348800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.450200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.46980205784075E-11 |
| Classical-VS-Follicular |
1.7110599999981E-05 |
| Classical-VS-Other |
8.746000E-01 |
| Classical-VS-Normal |
1.78079773149875E-12 |
| Tall-VS-Follicular |
1.64557256709941E-12 |
| Tall-VS-Other |
1.130770E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
2.053200E-01 |
| Follicular-VS-Normal |
2.074000E-01 |
| Other-VS-Normal |
1.811980E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.59490000000751E-05 |
| Normal-vs-N1 |
2.49110000405395E-08 |
| N0-vs-N1 |
1.522460E-02 |
|
|
